- Home
- SCSC vs IMNM Comparison
SCSC vs IMNM Comparison
Compare SCSC & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCSC
- IMNM
- Stock Information
- Founded
- SCSC 1992
- IMNM 2006
- Country
- SCSC United States
- IMNM United States
- Employees
- SCSC N/A
- IMNM N/A
- Industry
- SCSC Retail: Computer Software & Peripheral Equipment
- IMNM Medicinal Chemicals and Botanical Products
- Sector
- SCSC Technology
- IMNM Health Care
- Exchange
- SCSC Nasdaq
- IMNM Nasdaq
- Market Cap
- SCSC 892.3M
- IMNM 817.4M
- IPO Year
- SCSC 1994
- IMNM 2020
- Fundamental
- Price
- SCSC $43.99
- IMNM $11.71
- Analyst Decision
- SCSC
- IMNM Strong Buy
- Analyst Count
- SCSC 0
- IMNM 9
- Target Price
- SCSC N/A
- IMNM $24.89
- AVG Volume (30 Days)
- SCSC 251.7K
- IMNM 1.8M
- Earning Date
- SCSC 11-06-2025
- IMNM 11-12-2025
- Dividend Yield
- SCSC N/A
- IMNM N/A
- EPS Growth
- SCSC N/A
- IMNM N/A
- EPS
- SCSC 3.00
- IMNM N/A
- Revenue
- SCSC $3,040,810,000.00
- IMNM $12,589,000.00
- Revenue This Year
- SCSC $6.68
- IMNM N/A
- Revenue Next Year
- SCSC $4.22
- IMNM $154.70
- P/E Ratio
- SCSC $14.55
- IMNM N/A
- Revenue Growth
- SCSC N/A
- IMNM 16.74
- 52 Week Low
- SCSC $28.75
- IMNM $5.15
- 52 Week High
- SCSC $53.90
- IMNM $15.13
- Technical
- Relative Strength Index (RSI)
- SCSC 50.90
- IMNM 61.13
- Support Level
- SCSC $43.37
- IMNM $10.00
- Resistance Level
- SCSC $44.58
- IMNM $11.86
- Average True Range (ATR)
- SCSC 1.12
- IMNM 0.88
- MACD
- SCSC -0.14
- IMNM 0.25
- Stochastic Oscillator
- SCSC 30.95
- IMNM 82.52
About SCSC ScanSource Inc.
ScanSource Inc provides value-added services for technology manufacturers and sells to resellers in specialty technology markets. The firm's operations are organized in two segments: Specialty Technology Solutions and Modern Communications and Cloud. It generates maximum revenue from the Specialty Technology Solutions segment. The Specialty Technology Solutions segment includes the company's business in mobility and barcode, POS, payments, security and networking technologies. Geographically, it derives a majority of revenue from the United States.
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.